Clinical Trial

DEXA Bone Density Analysis of the CoreHip® Prosthesis System

Study acronym: CODEX
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-10-07; most recent amendment 2026-02-24.
Trial Details
NCT Number NCT06632301
Lead Sponsor Aesculap AG
Conditions Primary Osteoarthritis, Cartilage Degeneration, Osteoarthritis, Hip, Inflammatory Arthritis, Osteonecrosis of Femoral Head, Traumatic Disorder
Enrollment 40 participants
Start Date 2026-06
Primary Completion 2027-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-27